• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3
1
1
1

COUNTRY

1

CATEGORIES

  • 8
  • 7
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1

PRICE

5
5
19
25

PUBLISHED

0
1
17
25

PRODUCT TYPE

20
5

Search "Momenta Pharmaceuticals Inc-Therapeutic Competitors" returned 25 results.

Momenta Pharmaceuticals, Inc. (MNTA) - Financial and Strategic SWOT Analysis Review

Momenta Pharmaceuticals, Inc. (MNTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

May 2015
FROM

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH,...

September 2013
FROM

Encephalomyelitis - Pipeline Review, H2 2014

Encephalomyelitis - Pipeline Review, H2 2014 Summary This, ‘Encephalomyelitis - Pipeline Review, H2 2014’, provides an overview of the Encephalomyelitis’s therapeutic pipeline. This report provides...

November 2014
FROM

Encephalomyelitis - Pipeline Review, H1 2015

Encephalomyelitis - Pipeline Review, H1 2015 Summary This, ‘Encephalomyelitis - Pipeline Review, H1 2015’, provides an overview of the Encephalomyelitis’s therapeutic pipeline. This report provides...

February 2015
FROM

Pemphigus - Pipeline Review, H1 2015

Pemphigus - Pipeline Review, H1 2015 Summary This ‘Pemphigus - Pipeline Review, H1 2015’, provides an overview of the Pemphigus’s therapeutic pipeline. This report provides comprehensive information...

February 2015
FROM

Pemphigus - Pipeline Review, H2 2014

Pemphigus - Pipeline Review, H2 2014 Summary This, ‘Pemphigus - Pipeline Review, H2 2014’, provides an overview of the Pemphigus’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others)

This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others), is designed to provide a comprehensive look at the various strategies being used...

September 2013
FROM

Metastatic Pancreatic Cancer - Pipeline Review, H2 2014

Metastatic Pancreatic Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Pancreatic Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic...

July 2014
FROM

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015 Summary This, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review,...

February 2015
FROM

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2014

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2014 Summary This, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review,...

October 2014
FROM

Inflammation - Pipeline Review, H1 2014

Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Inflammation - Pipeline Review, H1 2014’, provides an overview of the Inflammation’s therapeutic pipeline. This report provides...

June 2014
FROM

Arthritis - Pipeline Review, H2 2014

Arthritis - Pipeline Review, H2 2014 Summary This, ‘Arthritis - Pipeline Review, H2 2014’, provides an overview of the Arthritis’s therapeutic pipeline. This report provides comprehensive information...

July 2014
FROM

Metastatic Pancreatic Cancer - Pipeline Review, H1 2014

Metastatic Pancreatic Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2014’, provides an overview of the Metastatic Pancreatic...

February 2014
FROM

Breast Cancer - Pipeline Review, H2 2014

Breast Cancer - Pipeline Review, H2 2014 Summary This, ‘Breast Cancer - Pipeline Review, H2 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM

Metastatic Melanoma - Pipeline Review, H2 2014

Metastatic Melanoma - Pipeline Review, H2 2014 Summary This, ‘Metastatic Melanoma - Pipeline Review, H2 2014’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline. This report...

September 2014
FROM

Breast Cancer - Pipeline Review, H1 2014

Breast Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report...

March 2014
FROM

Metastatic Melanoma - Pipeline Review, H1 2014

Metastatic Melanoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2014’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline. This...

March 2014
FROM

The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

“The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways” provides insights on the biosimilars market revenues and growth until 2015 Further, the distribution...

December 2009
FROM

Ariad Pharmaceuticals Incorporated

A textual analysis of the financial results for Ariad Pharmaceuticals Incorporated compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

March 2015
FROM

Sangamo Biosciences, Inc.

A textual analysis of the financial results for Sangamo Biosciences, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

March 2015
FROM
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.